Euroopa Liit - eesti - EMA (European Medicines Agency)

laboratoire aguettant - sufentanil citrate - valu - anesteetikumid - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.

Euroopa Liit - eesti - EMA (European Medicines Agency)

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - koerad - ravi mitte-resectable, mitte-metastaatilise (kes ülemineku) nahaaluse mast rakkude kasvajad, mis asub aadressil või kaugema et küünarnukk või kandadeni ja mitte-resectable, mitte metastaatilise naha mast cell kasvajate koerad.

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - eszopikloon - õhukese polümeerikattega tablett - 2mg 10tk; 2mg 30tk; 2mg 28tk; 2mg 20tk; 2mg 7tk; 2mg 50tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - eszopikloon - õhukese polümeerikattega tablett - 1mg 14tk; 1mg 28tk; 1mg 20tk; 1mg 98tk; 1mg 30tk; 1mg 100tk; 1mg 10tk; 1mg 56tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - eszopikloon - õhukese polümeerikattega tablett - 3mg 20tk; 3mg 98tk; 3mg 28tk; 3mg 100tk; 3mg 30tk; 3mg 10tk; 3mg 14tk; 3mg 50tk

Eesti - eesti - Ravimiamet

desitin arzneimittel gmbh - diasepaam - rektaallahus - 10mg 2.5ml 2.5ml 5tk

Eesti - eesti - Ravimiamet

teva b.v. - tiotroopium - inhalatsioonipulber kõvakapslis - 10mcg 60tk; 10mcg 15tk; 10mcg 30tk

Eesti - eesti - Ravimiamet

desitin arzneimittel gmbh - diasepaam - rektaallahus - 5mg 2.5ml 2.5ml 5tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastilised ained - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Eesti - eesti - Ravimiamet

woerwag pharma gmbh & co. kg - metformiin - õhukese polümeerikattega tablett - 1000mg 15tk; 1000mg 600tk; 1000mg 60tk; 1000mg 120tk